Trials / Completed
CompletedNCT05969834
HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome
Human Chorionic Gonadotropin Levels After Ovulation Triggering as Predictors of Intracytoplasmic Sperm Injection Outcome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to assess the correlation between HCG levels after ovulation triggering and ICSI outcomes, affected by HCG formulation and dose
Detailed description
The aims of this study are: 1. To assess the correlation between serum human chorionic gonadotropin (hCG) level after ovulation triggering and intracytoplasmic sperm injection (ICSI) outcome including: oocyte maturity and quality, good quality embryo rate, blastocyst formation rate and pregnancy rate 2. To determine if there is an association between type and dose of the trigger and ICSI outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | uHCG | Final oocyte maturation will be triggered by IM administration of 10000 IU of uHCG (Choriomon) |
| DRUG | rHCG | Final oocyte maturation will be triggered by SC administration of 6500 IU of rHCG (Ovitrelle) |
| DRUG | uHCG and GnRHa | Final oocyte maturation will be triggered by combined SC administration of 0.1 mg of GnRHa (Decapeptyl, Triptorelin) and IM administration of 2500 IU of uHCG (Choriomon) |
Timeline
- Start date
- 2021-03-31
- Primary completion
- 2022-07-19
- Completion
- 2022-08-07
- First posted
- 2023-08-01
- Last updated
- 2023-08-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05969834. Inclusion in this directory is not an endorsement.